Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia

World Journal of Gastroenterology

Volumn 9, Issue 11, 2003, Pages 2409-2412

  Zuo, Lian Fu ^a   Lin, Pei Zhong ^b   Qi, Fing Ying ^c   Guo, Jian Wen ^a   Liu, Jiang Hui ^a  

^a Department of Immunology   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; PROPIDIUM IODIDE; PROTEIN P21; PROTEIN P53; RAS PROTEIN; TELOMERASE;

ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CHINA; DATA ANALYSIS; DISEASE SEVERITY; DNA CONTENT; EARLY CANCER; EPITHELIUM CELL; EPITHELIUM DYSPLASIA; ESOPHAGUS CANCER; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE OVEREXPRESSION; HETEROPLOIDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MOLECULAR MECHANICS; PRECANCER; PROTEIN AGGREGATION; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

EID: 0345330229     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i11.2409     Document Type: Article

References (31)

1. Moreto M. Diagnosis of esophagogastric tumors. Endoscopy 2001; 33: 1-7
2. 53, PCNA and histopathologic study in primary achalasia: Preliminary results. Hepatogastroenterology 2001; 48: 408-412
3. 27 expression and DNA contents in esophagus carcinoma. Shiyong Aizheng Zazhi 2001; 16: 262-263
4. Zuo LF, Ling PZ, Qi FY, Wang JX, Ding ZW, Guo JW, Liu JH. Flow cytometric DNA analyses of epithelial dysplasia of the esophagus. Analyt Quant Cytol Histol 2000; 22: 175-177
5. 53. Zhonghuan Binglixue Zazhi 2000; 29: 60-62
6. 53 Ki67, and iNOS in human esophageal carcinoma in situ and pre-malignant lesions. Zhonghua Zhongliu Zazhi 2001; 23: 129-132.
7. 53 and cell-cycle related gene produces in the carcinogenesis of esophageal epithelia. Zhonghua Xin Yixue 2003; 4: 1345-1347
8. 53 expression in squamous dysplasia associated with carcinoma of the oesophagus: Evidence for field carcinogenesis. Br J Cancer 2000; 83: 1033-1038
9. Geboes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000; 37: 99-107
10. Shimada Y, Imamura M, Watanbae G, Ucida S, Harada H, Makino T, Kano M. Prognositic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 1999; 80: 1281-1288
11. Zhan XM, Wang GX, Sun CW, Wang JY, Li L. Expression of P16, P21, P53 and cyclin D1, and their significance in esophageal carcinoma. Shiyong Aizheng Zazhi 2001; 16: 36-38
12. Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type P53 and E2F-1 genes: Involvement of P53 accumulation via ARF-mediated MDM2 down-regulation. Clin Cancer Res 2000; 6: 2851-2859
13. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T. An immunohistochemical study of P16. PRb. P21 and P53 proteins in human esophageal cancers. Anticancer Res 2000; 20: 345-349
14. Xu M, Jin YL, Fu J, Huang H, Chen SZ, Qu P, Tian HM, Liu ZY, Zhang W. The abnormal expression of retinoic acid receptor-β, P53 and Ki 67 protein in normal, premalignant and malignant esophageal tissues. World J Gastroenterol 2002; 8: 200-202
15. Galiana C, Fusco A, Martel N, Nishihira T, Hirohashi S, Yamasaki H. Possible role of activated ras genes in human esophageal carcinogenesis. Int J Cancer 1993; 54: 978-982
16. Qiao GB, Han CL, Jiang RC, Sun CS, Wang Y, Wang YJ. Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xi'an. World J Gastroenterol 1998; 4: 57-60
17. Ikega G, Isaji S, Chandra B, Watanbe M, Kawarada Y. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999; 86: 1396-1405
18. Shinohara M, Aoki T, Sato S, Takagi Y, Osaka Y, Koyanagi Y, Hatooka S, Shinoda M. Cell-cycle regulated factors in esophageal cancer. Dis Esophagus 2002; 15: 149-154
19. Ohbu M, Kobayashi N, Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: Stepwise over-expression of cyclin E and P53, reduction of P21 (WAF1/CIP1) and dysregulation of cyclin D1 and P27 (KIP1). Histopathology 2001; 39: 589-596
20. Saeki H, Ohno S, Miyazaki M, Araki K, Egashira A, Kawaguchi H, Watanabe M, Morita M, Sugimachi K. P53 protein accumulation in multiple oesophageal squamous cell carcinoma: Relationship to risk factors. Oncology 2002; 62: 175-179
21. Fujii S, Tominaga O, Nagawa H, Tsuno N, Nita ME, Tsuruo T, Muto T. Quantitative analysis of the cyclin expression in human esophageal cancer cell lines. J Exp Clin Cancer Res 1998; 17: 491-496
22. Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Yamamoto M, Inoue M, Yano M, Monden M. Cyclin D1 overexpression in esophageal dysplasia: A possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 2000; 16: 261-266
23. Liu SX, Zuo LF, Zhang JY, Guo JW, Liu JH, Li YM. The expression of Rb, P21 and cyclin D1 in 41 esophageal cancers. Zhonghua Xin Yixue 2002; 3: 97-99
24. Toyoda H, Nakamura T, Shinoda M, Suzuki T, Hatooka S, Kobayashi S, Ohashi K, Seto M, Shiku H, Nakamura S. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas but not for superficial tumors. Dig Dis Sci 2000; 45: 864-869
25. 16, cyclin D1 and DNA content analysis in the carcinogenesis of esophageal epithelial cells. Zhonghua Xin Yixue 2001; 2: 1-3
26. Wu MY, Wu XY, Zhuang CX. The expression of human telomerase reverse transcriptase in esophageal squamous cell carcinoma and paracancerous esophageal epithelium. Shiyong Aizheng Zazhi 2003; 18: 132-134
27. Zhang LX, Qi FY, Zuo LF, Lin PZ, Guo JW, Liu JH. The quantitative analysis of telomerase and DNA ploid in the carcinogenesis of esophageal epithelium. Zhonghua Xin Yixue 2001; 2: 193-195
28. Shen ZY, Xu LY, Li EM, Cai WJ, Chen MH, Shen J, Zeng Y. Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell. World J Gastroenterol 2002; 8: 357-362
29. Koyanagi K, Ozawa S, Ando N, Takeuchi H, Ueda M, Kitajima M. Clinical significance of telomerase activity in the non cancerous epithelial region of oesophageal squamous cell carcinoma. Br J Surg 1999; 86: 674-679
30. Koyanagi K, Ozawa S, Ando N, Mukai M, Kitagawa Y, Ueda M, Kitajima M. Telomerase activity as an indicator of malignancy potential in iodine-nonreactive lesion of the esophagus. Cancer 2000; 88: 1524-1529
31. Rudolph P, Schubert C, Tamm C, Heidorm K, Hauschild A, Michalska I, Majewski S, Krupp G, Jablonska S, Parwaresch R. Telomerase activity in melanocytic lesions: A potential marker of tumor biology. Am J Path 2000; 156: 1425-1432